# Type 2 diabetes and its characteristics are associated with poor oral health: findings from 60,590 senior women from the E3N study

Nasser Laouali, Douae El Fatouhi, Gloria Aguayo, Beverley Balkau, Marie-Christine Boutron-Ruault, Fabrice Bonnet, Guy Fagherazzi

<figure><img src="image_1.png" /></figure>

## ► To cite this version:

Nasser Laouali, Douae El Fatouhi, Gloria Aguayo, Beverley Balkau, Marie-Christine Boutron-Ruault, et al.. Type 2 diabetes and its characteristics are associated with poor oral health: findings from 60,590 senior women from the E3N study. BMC Oral Health, 2021, 21 (1), pp.315. 10.1186/s12903-021-01679-w. hal-03285315

HAL Id: hal-03285315

https://hal.science/hal-03285315v1

Submitted on 13 Jul 2021

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>

Distributed under a Creative Commons CC BY 4.0 - Attribution - International License
RESEARCH

Open Access

<figure><img src="image_3.png" /></figure>

Check for
updates

# Type 2 diabetes and its characteristics are associated with poor oral health: findings from 60,590 senior women from the E3N study

Nasser Laouali<sup>1,2</sup>, Douae El Fatouhi<sup>1,2</sup>, Gloria Aguayo<sup>3</sup>, Beverley Balkau<sup>4</sup>, Marie-Christine Boutron-Ruault<sup>1,2</sup>, Fabrice Bonnet<sup>5</sup> and Guy Fagherazzi<sup>1,2,3*</sup>

**Abstract**

**Background:** Type 2 diabetes (T2D) has been identified as a risk factor for poor oral health, however, a limited number of oral health and T2D characteristics have been studied so far. We sought to assess T2D status, age at diagnosis, duration since diagnosis and treatment in relation to a variety of oral diseases.

**Methods:** Cross-sectional data were analyzed from the E3N (Etude Epidémiologique auprès de femmes de l'Education Nationale) cohort study which enrolled 60,590 women. Participants self-reported oral health status, and T2D cases were identified using diabetes-specific questionnaires and drug reimbursement insurance databases. Multivariable-adjusted ORs and 95% CIs were estimated using logistic regression models.

**Results:** The mean age (SD) of the women was 70 years (7.2), and 4.7% (n = 2857) had T2D. Compared to women without T2D, women with T2D were more likely to report a poor perceived oral health (OR 1.37 [95% CI 1.18, 1.60]), wearing dental prostheses (1.26 [1.14, 1.39]) and having problems of biting and chewing food (1.19 [1.07, 1.33]). In addition, for women with T2D the age at diagnosis (inversely) and the duration (positively) were associated with the likelihood to report poor oral health.

**Conclusions:** For women with T2D, duration and age at diagnosis are associated with wearing prostheses, problems of biting and chewing, periodontitis and gingivitis.

**Keywords:** Periodontitis, Gingivitis, Treatments, Aged, Female, Type 2 diabetes mellitus, Epidemiology

**Background**

Oral diseases are among the most common forms of chronic disease, with a strong effect on self-esteem, quality of life and overall health and well-being [1]. Although oral health is often uncared for in general health [1, 2], the World Health Organization (WHO) estimates that oral diseases affected fifty per cent of the global

population with untreated dental caries and severe peri-
odontal disease being the most prevalent diseases [1–3].
While all the underlying causes of oral health have not
yet been identified, several risk factors have been sug-
gested and may help our understanding of the funda-
mentals of oral disease pathophysiology. Among them,
oral hygiene and smoking are by far the most important
determinant, but diabetes has also been shown to play a
critical role [4, 5].

Indeed, type 2 diabetes is a chronic disease that has
concomitant oral manifestations that affect dental care.
Elevated levels of pro-inflammatory mediators in poorly
controlled diabetes play a role in the elevated risk of

<footnote>*Correspondence: Guy.Fagherazzi@lih.lu
¹Center for Research in Epidemiology and Population Health (CESP), Inserm (Institut National de la Santé Et de la Recherche Médicale) U1018, Generations and Health, Gustave Roussy Institute, 114 rue Edouard Vaillant, 94805 Villejuif Cedex, France
Full list of author information is available at the end of the article</footnote>
oral diseases such as periodontal destruction [6, 7]. For example, periodontal diseases (such as periodontitis and gingivitis) have been listed as the sixth most prevalent complication of diabetes [8]. It has also been reported that oral health may have an impact on type 2 diabetes risk and its metabolic control [1–3, 9], suggesting a complex bidirectional link between type 2 diabetes and oral diseases. However, there is more evidence that type 2 diabetes precedes periodontal diseases than the reverse [10, 11]. Previous data reported that diabetes duration and severity are positively associated with high decayed, missed and filled teeth values [12], periodontal diseases [13, 14], tooth loss [15] and lower scores of oral health related quality of life [16]. In contrast, a recent meta-analysis reports a non-significant association between poorly controlled type 2 diabetes and the risk of periodontitis as well as a high level of heterogeneity between studies [17]. The conflicting results highlight the need for further studies and there is no data in French population. In addition, while oral health is a general concept, a limited number of its characteristics have been used as outcomes in previous studies and no previous work has studied the various characteristics of oral health concomitantly. Furthermore, despite the gender differences in diabetes incidence [18] and the burden of age-related oral health [19], there are very few gender and age-specific studies.

Therefore, based on the detailed information from the large female E3N (Etude Epidémiologique auprès de femmes de l'Éducation Nationale) cohort study, we aim to evaluate the associations between type 2 diabetes and its characteristics (age at diagnosis, duration since diagnosis and treatment use) and oral health components in older women. Our hypothesis is that older women with type 2 diabetes are more likely to report poor oral health compared to older people without diabetes. In addition, diabetes duration and age at diagnosis are correlated with the likelihood of reporting poor oral health.

# Methods

## Cohort and study population for analysis

Women included in the present study are from the E3N cohort, a large ongoing French prospective cohort study, set up in 1990. The study was performed in accordance with the Declaration of Helsinki and received ethical approval from the French National Commission for Computerized Data and Individuals (CNIL); all participants gave written informed consent. The detailed protocol has been described elsewhere [20] and registered at clinicaltrials.gov as NCT03285230. Briefly, 98,995 women born between 1925 and 1950 were selected from the French national health insurance plan for teachers and coworkers, the Mutuelle Générale de l'Éducation Nationale. Data were collected at inclusion and every

2 years by self-administered questionnaires. Information recorded included health conditions, lifestyle, diet, treatments, etc. Furthermore, all outpatient reimbursements for health expenditure since January 1, 2004; of each participant were determined through a health insurance plan. These data included brand names, doses, and dates of drug reimbursements. The average response rate to a follow-up questionnaire is 83%, with a total loss to follow-up between 1990 and 2011 (date of wave 10 questionnaire which had items on oral health) was below 3%.

This study is a cross-sectional analysis of the E3N 10th wave questionnaire where 70,592 women completed information on oral health. From this sample, we further excluded all participants with missing data on one or more oral health items (n=9152) and all incident type 2 diabetes cases that occurred after December 07, 2011, date of the 10th wave questionnaire return (n=852). The final study population included 60,590 women (see Additional file 1: Fig. 1).

## Ascertainment of type 2 diabetes and its characteristics

The detailed procedure has been described in detail elsewhere [21]. Subsequently, a diabetes-specific questionnaire was sent to all potential cases identified through follow-up questionnaires. In order to be considered as validated, a potential case must have reported at least one of the following (1) fasting plasma glucose ≥ 7.0 mmol/l or random glucose ≥ 11.1 mmol/l at diagnosis; (2) use of a glucose-lowering medication; (3) values of fasting glucose or HbA1c concentrations ≥ 7.0 mmol/l or ≥ 7%, in the diabetes-specific questionnaire. After 2004, cases identification was based on the drug reimbursement insurance database. All women with at least two reimbursements for any glucose-lowering medications during 1 year were considered to have validated diabetes, with the date of diagnosis defined as the date of first reimbursement. For each validated case of type 2 diabetes, age at diagnosis, duration and treatment use were identified.

Age at diagnosis was calculated as the difference between the date of diagnosis and the date of birth. Diabetes duration was defined as the difference between December 12, 2011, date of wave 10 questionnaire return and the date of diagnosis. Treatment use considered was the last glucose lowering drug(s) [oral antidiabetic agents (OAD), insulin] used in the 6 months prior to the 10th wave questionnaire return. Anti-diabetic agents used were classified as OAD or insulin or the combination of OAD and insulin. Cases with no pharmacological treatment were also identified.

## Assessment of perceived oral health

Oral health status and behaviors were self-reported only in the 10th wave questionnaire (December 12, 2011) in
nine items adapted from the existing validated WHO oral health questionnaire for adults translated in French [22]. The adapted questionnaire was not validated. The following outcomes were considered: overall perception of oral health: good oral health, average oral health, poor oral health, information on teeth: yes, no (tooth loss, dental abscesses, problems of biting and chewing, dental prospects) as well as other conditions such as periodontitis and gingivitis diseases: yes, no. Daily brushing frequency and annual frequency of visits to the dentist were also considered as important characteristics of oral health and were used as adjusting factors in the modeling (see below).

## Covariables

In general, covariables used were measured at the 10th wave but if not available, we used the measurement at the closest wave for all women. BMI (wave 10 at 2011) was calculated by dividing weight in kilograms by height in meters squared and was considered as a continuous variable in all models. Age at wave 10, dietary inflammatory index [21] (wave 3 at 1993) and the level of recreational physical activity (wave 8 at 2005) (MET-h/week) were considered as continuous variables. Family history of diabetes (wave 8), personal history of hypertension (wave 9 at 2008) and hypercholesterolemia (wave 7 at 2002) were in two categories (yes and no). We considered three categories for smoking status (wave 10) (never, former, and current), educational level (wave 1 at 1990) (undergraduate or less, graduate, and postgraduate or more), and frequency of visits to the dentist (wave 10) (once a year or more, sometimes, and never). Daily brushing of teeth (wave 10) was considered in four categories (less than once, one, two, and three or more). Missing values were <5% for all variables and therefore were imputed by the median and mode for quantitative and qualitative variables, respectively. We use simple imputation as we have empirically shown that results were most often unchanged when using more complex imputation techniques such as multiple imputation when analyzing E3N data [21]. There are few missing data for covariables, overall that the imputation technique does not have any impact on the results.

## Statistical analysis

The distributions of the study population characteristics overall and by type 2 diabetes status were expressed as means and standard deviation (SD) for continuous variables and as number (percentage) for categorical variables. For type 2 diabetes cases, the distributions of those characteristics were also reported by quartile of diabetes duration, age at diabetes diagnosis, and type of treatment use. Crude and multivariable unconditional logistic

regressions were used to estimate associations between exposure variables (type 2 diabetes status, age at diagnosis, duration since diagnosis and treatment use) and outcome variables (self-reported oral health characteristics). For oral health perception considered in three levels (good, average and poor), we used multinomial logistic regression models. Odds ratios (OR) and their 95% confidence intervals (95% CI) were calculated in two different models: model 1 was unadjusted; model 2 was adjusted for age, educational level, smoking status, physical activity, family history of diabetes, hypercholesterolemia, hypertension, body mass index, dietary inflammatory index, daily brushing frequency and annual frequency of visits to the dentist.

In addition to our main analysis described previously, we tested for interactions between type 2 diabetes and BMI, smoking status and family history of diabetes as several studies draw a hypothetical picture of synergy between type 2 diabetes status and those variables in terms of damage to some oral diseases such as periodontitis [23–25]. As sensitivity analysis, we further adjusted model 2 for mentally tiring work (little or not, moderate, and high) assessed at wave 2 questionnaire (1992) and included as a categorical variable. Mentally tiring work, an indicator of work demands is a risk factor for several metabolic disorders and is associated with type 2 diabetes risk in our previous study in the E3N cohort [26].

All analyses were performed using Statistical Analysis Systems (SAS) software, version 9.3 (SAS Institute, Inc, Cary, NC, USA).

## Results

Overall, 4.7% (n=2857) of the women had type 2 diabetes at wave 10. Table 1 presents characteristics of women, overall and according to type 2 diabetes status. The overall mean (SD) age of the women was 70.2 (6.2) years. Compared with women without type 2 diabetes, women with type 2 diabetes tended to be older and more frequently had hypertension, hypercholesterolemia and a family history of diabetes (Table 1). In addition, they were more likely to declare less than one daily brushing of teeth and not visiting a dentist annually. Characteristics of women according to quartile groups of duration and age at diagnosis of type 2 diabetes and type of treatment use are presented in Additional file 1: Tables s1–s3.

## Type 2 diabetes status and perceived oral health

Figure 1 shows the OR of perceived oral health associated with type 2 diabetes. Women with type 2 diabetes were more likely to report a poor perceived oral health than women without type 2 diabetes [adjusted OR = 1.37 (95% CI 1.18 to 1.60)]. When the components of oral health outcome were further examined, women who had type
<figure><img src="image_4.png" /></figure>

2 diabetes were more likely to self-report wearing dental prostheses [adjusted OR = 1.26 (95% CI 1.14 to 1.39)] and having problems of biting and chewing food [adjusted OR = 1.19 (95% CI 1.07 to 1.33)] compared to women without type 2 diabetes. In the fully adjusted model, dental abscesses, tooth loss, periodontitis and gingivitis were not associated with type 2 diabetes status (Fig. 1).

## Type 2 diabetes duration and age at diagnosis and perceived oral health

Figure 2 shows the adjusted OR of perceived oral health associated with the duration of type 2 diabetes. We observed a positive association between type 2 diabetes duration and poor perceived oral health. Women with a long duration of type 2 diabetes (in the 4th quartile

group, ≥ 15 years) were more likely to report poor perceived oral health [adjusted OR = 1.76 (95% CI 1.17 to 2.66)] compared to women with short duration of type 2 diabetes (in the first quartile). With regards to components of oral health, women with type 2 diabetes for more than 15 years were more likely to report having periodontitis [adjusted OR = 2.14 (95% CI 1.37 to 3.33)], wearing dental prostheses [adjusted OR = 1.76 (95% CI 1.17 to 2.66)] and having lost teeth [adjusted OR = 1.25 (95% CI 0.95 to 1.65)] compared to women with short duration < 4 years (Figs. 2).

The same patterns of association were observed when age at diagnosis of type 2 diabetes was considered. Compared to women diagnosed at age 69 year or above (in the fourth quartile group), those diagnosed before the age of
<table><caption>**Table 1** Characteristics of the E3N study population, overall and according to diabetes status (N = 60,590 women), the E3N study</caption><thead><tr><th></th><th>All (N = 60,590)</th><th>Without type 2 diabetes (N = 57,733)</th><th>With type 2 diabetes (N = 2857)</th><th>P-value</th></tr></thead><tbody><tr><td>Age (years)</td><td>70.17 (6.22)</td><td>70.07 (6.20)</td><td>72.27 (6.35)</td><td>&lt; 0.0001</td></tr><tr><td>Educational level (%)</td><td></td><td></td><td></td><td>&lt; 0.0001</td></tr><tr><td>Undergraduate or less</td><td>6791 (11)</td><td>6315 (10.94)</td><td>476 (16.66)</td><td></td></tr><tr><td>Graduate</td><td>32,039 (53)</td><td>30,497 (52.82)</td><td>1542 (53.97)</td><td></td></tr><tr><td>Postgraduate or more</td><td>21,760 (36)</td><td>20,921 (36.24)</td><td>839 (29.37)</td><td></td></tr><tr><td>Physical activity (MET h/week)</td><td>59.56 (47.70)</td><td>59.88 (47.86)</td><td>53.12 (43.99)</td><td>&lt; 0.0001</td></tr><tr><td>Smoking status (%)</td><td></td><td></td><td></td><td>&lt; 0.0001</td></tr><tr><td>Never</td><td>2855 (4.71)</td><td>2748 (4.76)</td><td>107 (3.75)</td><td></td></tr><tr><td>Former</td><td>16,570 (27.35)</td><td>15,788 (27.35)</td><td>782 (27.37)</td><td></td></tr><tr><td>Current</td><td>41,165 (67.94)</td><td>39,197 (67.89)</td><td>1968 (68.88)</td><td></td></tr><tr><td>Dietary inflammatory index</td><td>0.12 (3.27)</td><td>0.14 (3.26)</td><td>-0.41 (3.30)</td><td>&lt; 0.0001</td></tr><tr><td>BMI (kg/m²)</td><td>24.03 (3.95)</td><td>23.86 (3.78)</td><td>27.53 (5.43)</td><td>&lt; 0.0001</td></tr><tr><td>Hypercholesterolemia (%)</td><td>6,830 (11)</td><td>6372 (11.04)</td><td>458 (16.03)</td><td>&lt; 0.0001</td></tr><tr><td>Hypertension (%)</td><td>9928 (16)</td><td>9056 (15.69)</td><td>872 (30.52)</td><td>&lt; 0.0001</td></tr><tr><td>Family history of diabetes (%)</td><td>7455 (12)</td><td>6672 (11.56)</td><td>783 (27.41)</td><td>&lt; 0.0001</td></tr><tr><td>Daily brushing (%)</td><td></td><td></td><td></td><td>&lt; 0.0001</td></tr><tr><td>Less than once</td><td>724 (1.20)</td><td>631 (1.09)</td><td>93 (3.26)</td><td></td></tr><tr><td>One</td><td>12,298 (20)</td><td>11,505 (19.93)</td><td>793 (27.76)</td><td></td></tr><tr><td>Two</td><td>29,533 (49)</td><td>28,190 (48.83)</td><td>1343 (47.01)</td><td></td></tr><tr><td>Three or more</td><td>18,035 (30)</td><td>17,407 (30.15)</td><td>628 (21.97)</td><td></td></tr><tr><td>Visits to the dentist (%)</td><td></td><td></td><td></td><td>0.0420</td></tr><tr><td>Once a year or more</td><td>43,300 (71.5)</td><td>41,358 (71.64)</td><td>1942 (67.97)</td><td></td></tr><tr><td>Sometimes</td><td>16,050 (26.5)</td><td>15,234 (26.38)</td><td>816 (28.56)</td><td></td></tr><tr><td>Never</td><td>1240 (2.0)</td><td>1141 (1.98)</td><td>99 (3.47)</td><td></td></tr></tbody></table>

N (%) and *p*-value of the Chi-square test for categorical variables

Mean (SD) and *p*-value of the Student test for continuous variables

Percent of missing data: Smoking status (3.7), educational level (4.0), daily brushing (0.2), visits to the dentist (0.4), BMI (4.5) and physical activity (2.6)

55 year were more likely to report poor perceived oral health (Fig. 3). In addition, their odds of reporting gingivitis were higher [adjusted OR = 1.49 (95% CI 1.03 to 2.17)].

## Type 2 diabetes treatment and perceived oral health

Table 2 shows the adjusted OR of perceived oral health associated with types 2 diabetes treatment used. After adjustment for multiple potential confounding covariates, the likelihood of poor perceived oral health was higher for women with type 2 diabetes with no pharmacological treatment [OR = 1.34 (95% CI 1.08 to 1.67)] or for those with current use of OAD [OR = 1.24 (95% CI 0.99 to 1.57)] or insulin [OR = 2.33 (95% CI 1.27 to 4.29)] or both OAD and insulin [OR = 2.47 (95% CI 1.38 to 4.42)] compared to women without type 2 diabetes (Table 2). With regards to components of oral health, women using OAD and insulin were more likely to report wearing dental prostheses [adjusted OR = 2.05 (95% CI 1.36 to 3.09)] and having loose teeth [adjusted OR = 1.80 (95% CI 1.18 to 2.75)] compared to women without

type 2 diabetes. In the fully adjusted model, the types of treatment were not associated with reporting dental abscesses, periodontitis and gingivitis.

There was no interaction between diabetes status and diabetes characteristics and BMI, smoking status and family history of diabetes on oral health. Further adjustment for mentally tiring work did not change the results (data not tabulated).

## Discussion

The present study demonstrates that older women with diabetes were more likely to report poor oral health than those without diabetes. Diabetes characteristics such as age at diabetes diagnosis, diabetes duration and diabetes treatment were also correlated with poor perceived oral health, even after adjusting for multiple potential confounders. With regards to components of oral health, diabetes duration and age at diagnosis were correlated with periodontitis and gingivitis in addition
<figure><img src="image_5.png" /></figure>

to wearing prostheses and problems of biting and chewing.

In the general population, oral health has been associated with low socioeconomic status and social security coverage [27]. Although in our study, all women were affiliated to the French national health insurance plan for teachers and our analyses took into account the level of education, we found an association between diabetes status and oral health. The high risk we observed would probably be higher in French women of the same age in the general population.

It has been found that individuals with diabetes have a higher prevalence or higher risk of oral health in several cross-sectional and prospective studies [28–30]. The main oral diseases explored so far in the literature

were periodontal disease and caries. For periodontal disease, the odds is increased approximately threefold in people with diabetes compared to the general population [31] and for dental caries, people with type 2 diabetes exhibit higher rates of dental caries and are at higher risk of caries developing [32, 33].

There are very few epidemiological studies directed to tooth loss, wearing prostheses and problems of biting and chewing, and studies are exclusively focused on the associations with diabetes status [4] and glycemic control [29, 30, 34–36]. Kapp et al. reported a correlation between diabetes and tooth loss in a population-based sample of adults [36]. A recent study in French population also reported that people with diabetes tend
<figure><img src="image_6.png" /></figure>

to undergo dental extractions earlier and more often compared to those without diabetes [29].

Few studies have considered the different characteristics of diabetes such as duration, age at diagnosis in relation to oral health, and none have included as many parameters as those included in this study. Three papers have previously shown an association between the duration of diabetes and a higher prevalence of oral health diseases [12, 37, 38]. Mohamed et al. reported that the level of coronal caries was significantly higher in long compared to short duration of type 2 diabetes group (≤ 10 years) [12]. In addition, Moore et al. reported that longer duration of diabetes was possibly related to partial tooth loss [37] and to periodontal disease [38]. Similarly, we have not been able to find any studies in the literature regarding the treatments used for diabetes in relation with oral health.

As first described by Seifert in 1862 and in recent studies, diabetes is a metabolic disorder with several manifestations that are also perceivable in the oral cavity [39, 40]. These manifestations include aberrant evolution of dentition, increased prevalence of caries and pathologies of the oral mucosa [32].

Considering the mechanisms that explain the high prevalence of poor overall oral health perception and tooth loss in women with diabetes compared to those without diabetes is the high glucose level in gingival crevicular fluid and saliva among diabetic patients, which favors the diffusion of microorganisms on the tooth surface [41, 42]. This accumulation of microorganisms accelerates the microbial accumulation by lowering the executing tendency of neutrophils, and then maximizes the odds of developing tooth decay among people with diabetes [32]. In addition, it has been suggested that there is a degree of synergism between diabetes and oral
<table><caption>**Table 2** Adjusted Odds ratios of self-reported oral health associated with types 2 diabetes treatment use (N=60,590 women), the E3N study</caption><thead><tr><th rowspan="2">Oral health characteristics</th><th rowspan="2">Number (%)</th><th colspan="2">Model<sup>a</sup></th><th colspan="2">Model<sup>b</sup></th></tr><tr><th>OR</th><th>95% CI</th><th>OR</th><th>95% CI</th></tr></thead><tbody><tr><td><strong>Oral health perception</strong></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Women without type 2 diabetes</td><td>32,932 (95.71)</td><td></td><td></td><td></td><td></td></tr><tr><td>Women with type 2 diabetes</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>No pharmacological treatment</td><td>702 (2.04)</td><td>541 (2.35)</td><td><strong>1.16</strong></td><td><strong>1.04-1.30</strong></td><td>1.06</td><td>0.95-1.19</td></tr><tr><td>Oral antidiabetic (OAD)</td><td>665 (1.93)</td><td>525 (2.28)</td><td><strong>1.19</strong></td><td><strong>1.06-1.33</strong></td><td>1.07</td><td>0.95-1.20</td></tr><tr><td>Insulin</td><td>57 (0.17)</td><td>59 (0.26)</td><td><strong>1.56</strong></td><td><strong>1.08-2.24</strong></td><td><strong>1.47</strong></td><td><strong>1.02-2.12</strong></td></tr><tr><td>OAD and insulin</td><td>56 (0.16)</td><td>42 (0.18)</td><td>1.13</td><td>0.76-1.69</td><td>1.00</td><td>0.66-1.48</td></tr><tr><td>Women without type 2 diabetes</td><td>32,932 (95.71)</td><td></td><td></td><td></td><td></td></tr><tr><td>Women with type 2 diabetes</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>No pharmacological treatment</td><td>702 (2.04)</td><td>100 (3.19)</td><td><strong>1.61</strong></td><td><strong>1.30-1.99</strong></td><td><strong>1.34</strong></td><td><strong>1.08-1.67</strong></td></tr><tr><td>OAD</td><td>665 (1.93)</td><td>89 (2.84)</td><td><strong>1.51</strong></td><td><strong>1.21-1.89</strong></td><td><strong>1.24</strong></td><td><strong>0.99-1.57</strong></td></tr><tr><td>Insulin</td><td>57 (0.17)</td><td>13 (0.41)</td><td><strong>2.57</strong></td><td><strong>1.41-4.70</strong></td><td><strong>2.33</strong></td><td><strong>1.27-4.29</strong></td></tr><tr><td>OAD and insulin</td><td>56 (0.16)</td><td>15 (0.48)</td><td><strong>3.03</strong></td><td><strong>1.71-5.36</strong></td><td><strong>2.47</strong></td><td><strong>1.38-4.42</strong></td></tr><tr><td><strong>Dental prosthesis</strong></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Women without type 2 diabetes</td><td>49,107 (95.67)</td><td>8626 (93)</td><td></td><td></td><td></td></tr><tr><td>Women with type 2 diabetes</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>No pharmacological treatment</td><td>1048 (2.04)</td><td>295 (3.20)</td><td><strong>1.60</strong></td><td><strong>1.41-1.83</strong></td><td><strong>1.26</strong></td><td><strong>1.10-1.45</strong></td></tr><tr><td>OAD</td><td>1000 (1.95)</td><td>279 (3.00)</td><td><strong>1.59</strong></td><td><strong>1.39-1.82</strong></td><td><strong>1.21</strong></td><td><strong>1.05-1.40</strong></td></tr><tr><td>Insulin</td><td>105 (0.20)</td><td>24 (0.30)</td><td>1.30</td><td>0.84-2.03</td><td>1.11</td><td>0.70-1.75</td></tr><tr><td>OAD and insulin</td><td>76 (0.15)</td><td>37 (0.40)</td><td><strong>2.77</strong></td><td><strong>1.87-4.11</strong></td><td><strong>2.05</strong></td><td><strong>1.36-3.09</strong></td></tr><tr><td><strong>Problems of biting and chewing</strong></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Women without type 2 diabetes</td><td>51,011 (95.47)</td><td>6722 (93.88)</td><td></td><td></td><td></td></tr><tr><td>Women with type 2 diabetes</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>No pharmacological treatment</td><td>1132 (2.12)</td><td>211 (2.95)</td><td><strong>1.42</strong></td><td><strong>1.22-1.64</strong></td><td><strong>1.24</strong></td><td><strong>1.06-1.44</strong></td></tr><tr><td>OAD</td><td>1089 (2.04)</td><td>190 (2.65)</td><td><strong>1.32</strong></td><td><strong>1.13-1.55</strong></td><td>1.14</td><td>0.97-1.34</td></tr><tr><td>Insulin</td><td>110 (0.21)</td><td>19 (0.27)</td><td>1.31</td><td>0.81-2.14</td><td>1.21</td><td>0.74-1.99</td></tr><tr><td>OAD and insulin</td><td>95 (0.18)</td><td>18 (0.25)</td><td>1.44</td><td>0.87-2.38</td><td>1.23</td><td>0.74-2.06</td></tr><tr><td><strong>Dental abscess</strong></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Women without type 2 diabetes</td><td>54,208 (95.28)</td><td>3525 (95.35)</td><td></td><td></td><td></td></tr><tr><td>Women with type 2 diabetes</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>No pharmacological treatment</td><td>1263 (2.22)</td><td>80 (2.16)</td><td>0.97</td><td>0.78-1.22</td><td>0.94</td><td>0.75-1.19</td></tr><tr><td>OAD</td><td>1208 (2.12)</td><td>71 (1.92)</td><td>0.90</td><td>0.71-1.15</td><td>0.89</td><td>0.69-1.14</td></tr><tr><td>Insulin</td><td>116 (0.20)</td><td>13 (0.35)</td><td>1.72</td><td>0.97-3.06</td><td>1.72</td><td>0.96-3.06</td></tr><tr><td>OAD and insulin</td><td>105 (0.18)</td><td>8 (0.22)</td><td>1.17</td><td>0.57-2.41</td><td>1.40</td><td>0.55-2.36</td></tr><tr><td><strong>Tooth loss</strong></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Women without type 2 diabetes</td><td>46,950 (95.29)</td><td>10,783 (95.28)</td><td></td><td></td><td></td></tr><tr><td>Women with type 2 diabetes</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>No pharmacological treatment</td><td>1081 (2.19)</td><td>262 (2.32)</td><td>1.06</td><td>0.92-1.21</td><td>1.11</td><td>0.96-1.27</td></tr><tr><td>OAD</td><td>1063 (2.16)</td><td>216 (1.91)</td><td>0.89</td><td>0.76-1.03</td><td>0.97</td><td>0.83-1.13</td></tr><tr><td>Insulin</td><td>102 (0.21)</td><td>27 (0.24)</td><td>1.15</td><td>0.75-1.76</td><td>1.14</td><td>0.74-1.75</td></tr><tr><td>OAD and insulin</td><td>83 (0.17)</td><td>30 (0.27)</td><td><strong>1.58</strong></td><td><strong>1.04-2.39</strong></td><td><strong>1.80</strong></td><td><strong>1.18-2.75</strong></td></tr><tr><td><strong>Periodontitis</strong></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Women without type 2 diabetes</td><td>53,040 (95.21)</td><td>4693 (96.13)</td><td></td><td></td><td></td></tr><tr><td>Women with type 2 diabetes</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>No pharmacological treatment</td><td>1260 (2.26)</td><td>83 (1.70)</td><td><strong>0.75</strong></td><td><strong>0.60-0.93</strong></td><td>0.84</td><td>0.67-1.06</td></tr><tr><td>OAD</td><td>1189 (2.13)</td><td>90 (1.84)</td><td>0.86</td><td>0.69-1.06</td><td>1.05</td><td>0.84-1.31</td></tr></tbody></table>
<table><caption>**Table 2** (continued)</caption><thead><tr><th rowspan="2">Oral health characteristics</th><th rowspan="2">Number (%)</th><th colspan="2">Model<sup>a</sup></th><th colspan="2">Model<sup>b</sup></th></tr><tr><th>OR</th><th>95% CI</th><th>OR</th><th>95% CI</th></tr></thead><tbody><tr><td>Insulin</td><td>120 (0.22)</td><td>0.85</td><td>0.43-1.67</td><td>0.89</td><td>0.45-1.76</td></tr><tr><td>OAD and insulin</td><td>105 (0.19)</td><td>0.86</td><td>0.42-1.77</td><td>1.13</td><td>0.55-2.34</td></tr><tr><td><strong>Gingivitis</strong></td><td><strong>No</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>Women without type 2 diabetes</td><td>49,660 (95.26)</td><td>1.00</td><td>Reference</td><td>1.00</td><td>Reference</td></tr><tr><td>Women with type 2 diabetes</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>No pharmacological treatment</td><td>1150 (2.21)</td><td>1.03</td><td>0.89-1.21</td><td>1.10</td><td>0.94-1.29</td></tr><tr><td>OAD</td><td>1124 (2.16)</td><td>0.85</td><td>0.72-1.01</td><td>0.94</td><td>0.79-1.12</td></tr><tr><td>Insulin</td><td>106 (0.20)</td><td>1.34</td><td>0.85-2.10</td><td>1.42</td><td>0.90-2.23</td></tr><tr><td>OAD and insulin</td><td>99 (0.19)</td><td>0.87</td><td>0.50-1.52</td><td>0.99</td><td>0.56-1.75</td></tr></tbody></table>

Data in bold indicate statistically significant associations

CI, Confidence interval; OR, Odds ratios; OAD, Oral antidiabetic treatment

diseases such as periodontal diseases [28, 43]. Inflammation plays a central role in both periodontal diseases and diabetes. Inflammatory processes are controlled in the periodontal tissues of people with diabetes and, on the other hand, the presence of periodontal diseases can have an effect on the metabolic control in diabetes, explaining thus, in part, the bidirectional relationship of these two diseases [43]. In the fully adjusted model, we did not find any association between type 2 diabetes status and inflammatory dental diseases (dental abscesses, periodontitis and gingivitis). Interestingly, long duration and early age at diagnosis of type 2 diabetes were related to these inflammatory dental diseases. This may suggest that more severe diabetes or comorbidities were involved in the association between diabetes and periodontal diseases. In addition, diabetes duration and age at diagnosis are likely associated with metabolic control. It may explain the research showing a greater rate of people with poor glycemic control in people who have periodontitis compared with people with diabetes who do not have periodontitis, as well as the research showing improvement in glycemic control after periodontal therapy in people with diabetes [44].

Our study presents several strengths. First, the E3N study included a large number of participants, and the large number of participants with type 2 diabetes ensured a high statistical power, however some analyses where the number of participants with specific oral disease was more limited and should be interpreted with caution. Second, we simultaneously evaluated in the same population, various oral health components in relation with diabetes status and diabetes characteristics. Finally, we were able to adjust our analyses for numerous risk factors as

potential confounders, including daily brushing of teeth and annual frequency of visits to the dentist. Our study also has limitations. First, the study is cross-sectional and cannot provide information regarding causality nor temporality. Second, the lack of data on HbA1c level and ethnicity/race prevents us from adjusting our analyses for these variables. Third, the use of non-validated self-reported questionnaires to assess oral health could lead to a risk of bias, we believe that there is a limited risk of having a differential bias between the two groups compared, namely women with and without diabetes. Moreover, in our study, 98% of the women reported visiting a dentist regularly; which increases the reliability of the diagnosis of the events like periodontitis and gingivitis which can be diagnosed only by a professional. Fourth, not all covariables were obtained from the 10th wave questionnaire. However, availability of data at E3N cohort study recruitment and over the follow-up allowed us to incorporate measurement of the closest wave. Fifth, we could not include all the population because of the missing data on one or more oral health items, however, the 60,590 women included did not differ from the 9152 others in terms of age, sociodemographic characteristics, and risk factors. Seventhly, our study population was exclusively composed of women; however, this limitation should have been minor because no difference in biological mechanisms has been reported between men and women regarding the influence of diabetes and its characteristics on oral health. Finally, our results are not directly generalizable to the French population because the E3N cohort is composed of women who were affiliated to the French national health insurance plan for teachers, the *Mutuelle Générale de l'Éducation Nationale*.

<footnote><sup>a</sup> Model 1: unadjusted</footnote>

<footnote><sup>b</sup> Model 2: adjusted for age at wave 10, educational level, smoking status, physical activity, family history of diabetes, hypercholesterolemia, hypertension, body mass index, dietary inflammatory index, daily brushing frequency and annual frequency of visits to the dentist</footnote>
They therefore represent a selected population of French women. However, it has been previously shown that an important socio-demographic gradient exists in the E3N cohort study which ensures a high diversity in the profiles of the study participants [45].

## Conclusion

The results of our study contribute to fill the gap in the existing literature by showing an association between type 2 diabetes and oral diseases, independent of daily brushing of teeth and the frequency of visits to the dentist. We have shown that diabetes duration and age at diagnosis are cross-sectionally associated with wearing prostheses, problems of biting and chewing, periodontitis and gingivitis. Type 2 diabetes treatments which provide some idea of the severity of the diabetes are also associated with oral health characteristics except inflammatory dental diseases. Given the predicted increase in the prevalence of diabetes, our results suggest a need for specific prevention strategies to preserve oral health in this at-risk population.

## Abbreviations

CNIL: Commission for Computerized Data and Individuals; E3N: Etude Epidémiologique auprès de femmes de l'Éducation Nationale; T2D: Type 2 diabetes; CI: Confidence interval; OR: Odds ratios; OAD: Oral antidiabetic treatment; ESM: Electronic supplementary material; WHO: World Health Organization; SD: Standard deviation; SAS: Statistical analysis systems.

## Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1186/s12903-021-01679-w.

**Additional file 1. Table s1:** Characteristics of the E3N study population according to diabetes duration (N = 60,590). **Table s2:** Characteristics of the E3N study population according to age at diabetes diagnosis (N = 60,590). **Table s3:** Characteristics of the E3N study population according to diabetes treatment (N = 60,590). **Figure s1:** Flowchart representing the constitution of the study sample.

## Acknowledgements

The authors are indebted to all participants for their continued participation. They are also grateful to all members of the E3N study group.

## Authors' contributions

NL, BB and GF conceived and designed the study. NL performed the statistical analysis and drafted the original manuscript. DEF, GA, MCBR and FB contributed to the interpretation of the results discussed in the manuscript, revised the manuscript and approved its final version to be published. All authors read and approved the final manuscript.

## Funding

This work was supported by a grant for the Nutriperso Project (IDEX Paris Saclay). This research was carried out using data from Inserm's E3N cohort with the support of the MGEN, the Institut GUSTAVE ROUSSY and the Ligue contre le Cancer for the constitution and maintenance of the E3N cohort. This work has also benefited from State aid managed by the National Research Agency under the program "Investissement d'avenir" under the reference ANR-10-COHO-0006 as well as a subsidy from the "Ministère de l'enseignement supérieur, de la recherche et de l'innovation" for public service charges under the reference n°2102 918823. Guy Fagherazzi is supported by the Luxembourg Institute of Health. The funders had no role in study design, data collection and analysis, writing the manuscript, decision to publish, or preparation of manuscript.

## Availability of data and materials

The datasets generated during and/or analysed for the current study are available from the corresponding author on reasonable request.

## Declarations

### Ethics approval and consent to participate

All procedures performed in studies involving human participants were approved by the Ethics Committee of the French National Commission for Computerized Data and Individuals (CNIL) and were in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The study was explained, and written informed consent was obtained from the participants.

### Consent for publication

Not applicable.

### Competing interests

The authors declare that they have no competing interests associated with this manuscript.

### Author details

¹Center for Research in Epidemiology and Population Health (CESP), Inserm (Institut National de la Santé Et de la Recherche Médicale) U1018, Generations and Health, Gustave Roussy Institute, 114 rue Edouard Vaillant, 94805 Villejuif Cedex, France. ²Faculté de Médecine, UPS-UVSQ-Paris-Saclay University, 94270 Le Kremlin-Bicêtre Cedex, France. ³Deep Digital Phenotyping Research Unit, Department of Population Health, Luxembourg Institute of Health, 1A-B, rue Thomas Edison, 1445 Strassen, Luxembourg. ⁴Center for Research in Epidemiology and Population Health (CESP), Inserm (Institut National de la Santé et de la Recherche Médicale) U1018, Clinical Epidemiology, 16 Avenue Paul Vaillant Couturier, 94807 Villejuif, France. ⁵Department of Endocrinology, Diabetes and Nutrition, CHU Rennes, Université de Rennes 1, Rennes, France.

Received: 25 February 2021 Accepted: 9 June 2021

Published online: 23 June 2021

## References

1. Jin LJ, Lamster IB, Greenspan JS, Pitts NB, Scully C, Warnakulasuriya S. Global burden of oral diseases: emerging concepts, management and interplay with systemic health. Oral Dis. 2016;22:609–19.

2. Watt RG, Daly B, Allison P, Macpherson LMD, Venturelli R, Listl S, et al. Ending the neglect of global oral health: time for radical action. Lancet. 2019;394:261–72.

3. World Health Organization. The World Health Report 2003: Shaping the future. World Health Organization; 2003.

4. Patel MH, Kumar JV, Moss ME. Diabetes and tooth loss: an analysis of data from the National Health and Nutrition Examination Survey, 2003–2004. J Am Dent Assoc. 2013;144:478–85.

5. Albert DA, Ward A, Allweiss P, Graves DT, Knowler WC, Kunzel C, et al. Diabetes and oral disease: implications for health professionals. Ann NY Acad Sci. 2012;1255:1–15.

6. Sanz M, Ceriello A, Buysschaert M, Chapple I, Demmer RT, Graziani F, et al. Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology. J Clin Periodontol. 2018;45:138–49.

7. Parbhakar KK, Rosella LC, Singhal S, Quiñonez CR. Risk of complications among diabetics self-reporting oral health status in Canada: a population-based cohort study. PLoS ONE. 2020;15: e0218056. https://doi.org/10.1371/journal.pone.0218056.
8. Loe H. Periodontal disease: the sixth complication of diabetes mellitus. Diabetes Care. 1993;16:329–34. https://doi.org/10.2337/diacare.16.1.329.

9. Sora ND, Marlow NM, Bandyopadhyay D, Leite RS, Slate EH, Fernandes JK. Metabolic syndrome and periodontitis in Gullah African Americans with type 2 diabetes mellitus. J Clin Periodontol. 2013;40:599–606.

10. Taylor JJ, Preshaw PM, Lalla E. A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Periodontol. 2013;84(4 Suppl):S113–34.

11. Casanova L, Hughes FJ, Preshaw PM. Diabetes and periodontal disease: a two-way relationship. Br Dent J. 2014;217:433–7.

12. Mohamed HG, Idris SB, Ahmed MF, Bœ OE, Mustafa K, Ibrahim SO, et al. Association between oral health status and type 2 diabetes mellitus among Sudanese adults: a matched case-control study. PLoS ONE. 2013;8:e82158.

13. Saremi A, Nelson RG, Tulloch-Reid M, Hanson RL, Sievers ML, Taylor GW, et al. Periodontal disease and mortality in type 2 diabetes. Diabetes Care. 2005;28:27–32.

14. Meenawat A, Punn K, Srivastava V, Meenawat AS, Dolas RS, Govila V. Periodontal disease and type I diabetes mellitus: associations with glycemic control and complications. J Indian Soc Periodontol. 2013;17:597–600.

15. Santos VR, Lima JA, Miranda TS, Feres M, Zimmermann GS, Nogueira-Filho GR, et al. Relationship between glycemic subsets and generalized chronic periodontitis in type 2 diabetic Brazilian subjects. Arch Oral Biol. 2012;57:293–9.

16. Sadeghi R, Taleghani F, Farhadi S. Oral health related quality of life in diabetic patients. J Dent Res Dent Clin Dent Prospects. 2014;8:230–4.

17. Wu C-Z, Yuan Y-H, Liu H-H, Li S-S, Zhang B-W, Chen W, et al. Epidemiologic relationship between periodontitis and type 2 diabetes mellitus. BMC Oral Health. 2020;20:204.

18. Earle KA, Ng L, White S, Zitouni K. Sex differences in vascular stiffness and relationship to the risk of renal functional decline in patients with type 2 diabetes. Diab Vasc Dis Res. 2017;14:304–9.

19. Ramsay SE, Whincup PH, Watt RG, Tsakos G, Papacosta AO, Lennon LT, et al. Burden of poor oral health in older age: findings from a population-based study of older British men. BMJ Open. 2015;5:e009476.

20. Clavel-Chapelon F, for the E3N Study Group. Cohort Profile: The French E3N Cohort Study. Int J Epidemiol. 2014;44:801–9.

21. Laouali N, Mancini FR, Hajji-Louati M, El Fatouhi D, Balkau B, Boutron-Ruault M-C, et al. Dietary inflammatory index and type 2 diabetes risk in a prospective cohort of 70,991 women followed for 20 years: the mediating role of BMI. Diabetologia. 2019;62:2222–32.

22. Narayan DP. Assessment of oral health status using WHO basic oral health survey form. Clin Manual Public Health Dentistry Pract Rec Book. 2015. https://doi.org/10.5005/jp/books/12448_20.

23. Battancs E, Gheorghita D, Nyiraty S, Lengyel C, Eördegh G, Baráth Z, et al. Periodontal disease in diabetes mellitus: a case-control study in smokers and non-smokers. Diabetes Ther. 2020;11:2715–28.

24. Gupta N, Gupta ND, Garg S, Goyal L, Gupta A, Khan S, et al. The effect of type 2 diabetes mellitus and smoking on periodontal parameters and salivary matrix metalloproteinase-8 levels. J Oral Sci. 2016;58:1–6.

25. Levine RS. Obesity, diabetes and periodontitis—a triangular relationship? Br Dent J. 2013;215:35–9.

26. Fagherazzi G, Gusto G, El Fatouhi D, Mancini FR, Balkau B, Boutron-Ruault M-C, et al. Mentally tiring work and type 2 diabetes in women: a 22-year follow-up study. Eur J Endocrinol. 2019;180:257–63.

27. Heredia-Ponce E, Irigoyen-Camacho AE, Sánchez-García S. Oral health status of Institutionalized older women from different socioeconomic positions. J Health Care Poor Underserved. 2017;28:1462–76.

28. Mauri-Obradors E, Estrugo-Devesa A, Jane-Salas E, Vinas M, Lopez-Lopez J. Oral manifestations of diabetes mellitus a systematic review. Medicina Oral Patologia Oral y Cirugia Bucal. 2017. https://doi.org/10.4317/medor al.21655.

29. Mayard-Pons ML, Rilliard F, Libersa JC, Musset AM, Farge P. Database analysis of a French type 2 diabetic population shows a specific age pattern of tooth extractions and correlates health care utilization. J Diabetes Complicat. 2015;29:993–7.

30. Yoo J-J, Kim D-W, Kim M-Y, Kim Y-T, Yoon J-H. The effect of diabetes on tooth loss caused by periodontal disease: a nationwide population-based cohort study in South Korea. J Periodontol. 2019;90:576–83.

31. Mealey BL. Diabetes and periodontal disease: two sides of a coin. Compend Contin Educ Dent. 2000;21:943–6, 948, 950, passim; quiz 956.

32. Singh I, Singh P, Singh A, Singh T, Kour R. Diabetes an inducing factor for dental caries: a case control analysis in Jammu. J Int Soc Prev Community Dent. 2016;6:125–9.

33. Latti BR, Kalburge JV, Birajdar SB, Latti RG. Evaluation of relationship between dental caries, diabetes mellitus and oral microbiota in diabetics. J Oral Maxillofac Pathol. 2018;22:282.

34. Oates TW, Huynh-Ba G, Vargas A, Alexander P, Feine J. A critical review of diabetes, glycemic control, and dental implant therapy. Clin Oral Implants Res. 2013;24:117–27.

35. Carneiro VL, Fraiz FC, Ferreira FM, Pintarelli TP, Oliveira ACB, Boguszewski MCS. The influence of glycemic control on the oral health of children and adolescents with diabetes mellitus type 1. Arch Endocrinol Metab. 2015;59:535–40.

36. Kapp JM, Boren SA, Yun S, LeMaster J. Diabetes and tooth loss in a national sample of dentate adults reporting annual dental visits. Prev Chronic Dis. 2007;4:A59.

37. Moore PA, Weyant RJ, Mongelluzzo MB, Myers DE, Rossie K, Guggenheimer J, et al. Type 1 diabetes mellitus and oral health: assessment of tooth loss and edentulism. J Public Health Dent. 1998;58:135–42.

38. Moore PA, Weyant RJ, Mongelluzzo MB, Myers DE, Rossie K, Guggenheimer J, et al. Type 1 diabetes mellitus and oral health: assessment of periodontal disease. J Periodontol. 1999;70:409–17.

39. Isola G, Matarese G, Ramaglia L, Pedullà E, Rapisarda E, Iorio-Siciliano V. Association between periodontitis and glycosylated haemoglobin before diabetes onset: a cross-sectional study. Clin Oral Investig. 2020;24:2799–808.

40. Preshaw PM, Bissett SM. Periodontitis and diabetes. BDJ Team. 2020;7:27–35. https://doi.org/10.1038/s41407-020-0311-3.

41. Campus G, Salem A, Uzzau S, Baldoni E, Tonolo G. Diabetes and periodontal disease: a case-control study. J Periodontol. 2005;76:418–25. https://doi.org/10.1902/jop.2005.76.3.418.

42. Ribeiro FV, de Mendonça AC, Santos VR, Bastos MF, Figueiredo LC, Duarte PM. Cytokines and bone-related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis. J Periodontol. 2011;82:1187–96.

43. Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol. 2001;6:99–112.

44. Mealey BL. Periodontal disease and diabetes. A two-way street. J Am Dent Assoc. 2006;137(Suppl):26S-31S.

45. Affret A, Severi G, Dow C, Mancini FR, Rey G, Delpierre C, et al. Socio-economic factors associated with an increase in fruit and vegetable consumption: a 12-year study in women from the E3N-EPIC study. Public Health Nutr. 2018;21:740–55.

**Publisher's Note**

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.